20 year experience of postoperative radiotherapy in IB-IIA cervical cancer patients with intermediate risk factors: Impact of treatment period and concurrent chemotherapy

Gynecologic Oncology

Volumn 124, Issue 1, 2012, Pages 63-67

  Song, Sanghyuk ^a   Song, Changhoon ^a   Kim, Hak Jae ^a   Wu, Hong Gyun ^a,b   Kim, Jin Ho ^a   Park, Noh Hyun ^a   Song, Yong Sang ^a   Kim, Jae Weon ^a   Kang, Soon Beom ^a   Ha, Sung W ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Cervical cancer; Chemotherapy; Intermediate risk factors; Postoperative radiotherapy

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL; PACLITAXEL;

ADD ON THERAPY; ADJUVANT THERAPY; ADULT; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; INTERMETHOD COMPARISON; LYMPH VESSEL; LYMPHATIC SYSTEM DISEASE; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NEUROLOGIC DISEASE; NEUROTOXICITY; NEUTROPENIA; PELVIS; POSTOPERATIVE CARE; PRIORITY JOURNAL; RISK FACTOR; STROMA CELL; TREATMENT OUTCOME; TUMOR VOLUME; UROGENITAL TRACT DISEASE; UTERINE CERVIX CANCER;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHEMORADIOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PACLITAXEL; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 83055187943     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.09.033     Document Type: Article

References (30)

1. P.J. Eifel, J.S. Berek, and M.A. Markman Cancer of the cervix, vagina, and vulva V.T. DeVita, T.S. Lawrence, S.A. Rosenberg, Cancer: principles and practice of concology 2008 Lippincott Williams and Wilkins Philadelphia 1507 1511
2. F. Landoni, A. Maneo, and A. Colombo Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer Lancet 350 9077 1997 535 540 (Pubitemid 27348428)
3. C.K. Chung, W.A. Nahhas, J.A. Stryker, S.L. Curry, A.B. Abt, and R. Mortel Analysis of factors contributing to treatment failures in stages IB and IIA carcinoma of the cervix Am J Obstet Gynecol 138 5 1980 550 556 (Pubitemid 11250683)
4. J. Boyce, R.G. Fruchter, A.D. Nicastri, P.C. Ambiavagar, M.S. Reinis, and J.H. Nelson Jr. Prognostic factors in stage I Carcinoma of the cervix Gynecol Oncol 12 2 Pt 1 1981 154 165 (Pubitemid 12239321)
5. J.R. van Nagell Jr. , E.S. Donaldson, E.G. Wood, and J.C. Parker Jr. The significance of vascular invasion and lymphocytic infiltration in invasive cervical cancer Cancer 41 1 1978 228 234 (Pubitemid 8286432)
6. G. Delgado, B. Bundy, R. Zaino, B.U. Sevin, W.T. Creasman, and F. Major Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study Gynecol Oncol 38 3 1990 352 357 (Pubitemid 20362555)
7. R.A. Samlal, J. van der Velden, and M.S. Schilthuis Identification of high-risk groups among node-positive patients with stage IB and IIA cervical carcinoma Gynecol Oncol 64 3 1997 463 467 (Pubitemid 27120437)
8. A.F. Fuller Jr. , N. Elliott, C. Kosloff, W.J. Hoskins, and J.L. Lewis Jr. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix Gynecol Oncol 33 1 1989 34 39 (Pubitemid 19106619)
9. W.A. Peters III, P.Y. Liu, and R.J. Barrett II Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 8 2000 1606 1613 (Pubitemid 30220538)
10. A. Sedlis, B.N. Bundy, M.Z. Rotman, S.S. Lentz, L.I. Muderspach, and R.J. Zaino A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a gynecologic oncology group study Gynecol Oncol 73 2 1999 177 183 (Pubitemid 29215728)
11. M. Rotman, A. Sedlis, and M.R. Piedmonte A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study Int J Radiat Oncol Biol Phys 65 1 2006 169 176
12. S.Y. Ryu, S.I. Park, and B.H. Nam Is adjuvant chemoradiotherapy overtreatment in cervical cancer patients with intermediate risk factors? Int J Radiat Oncol Biol Phys 79 3 2011 794 799
13. S. Mabuchi, K. Morishige, and F. Isohashi Postoperative concurrent nedaplatin-based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors Gynecol Oncol 115 3 2009 482 487
14. K. Kim, S.B. Kang, H.H. Chung, J.W. Kim, N.H. Park, and Y.S. Song Comparison of chemoradiation with radiation as postoperative adjuvant therapy in cervical cancer patients with intermediate-risk factors Eur J Surg Oncol 35 2 2009 192 196
15. http://ctep.cancer.gov/protocolDevelopment/electronic-applications/docs/ ctcaev3.pdf
16. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 5 1995 1341 1346
17. C.W. Whitney, W. Sause, and B.N. Bundy Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study J Clin Oncol 17 5 1999 1339 1348 (Pubitemid 29220838)
18. P.G. Rose, B.N. Bundy, and E.B. Watkins Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 15 1999 1144 1153 (Pubitemid 29177873)
19. M. Morris, P.J. Eifel, and J. Lu Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer N Engl J Med 340 15 1999 1137 1143 (Pubitemid 29177872)
20. H.M. Keys, B.N. Bundy, and F.B. Stehman Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 340 15 1999 1154 1161 (Pubitemid 29177874)
21. The Cancer Trials Support Unit databases http://www.ctsu.org/public/data/ protocols/GOG/GOG-0263/pfs.pdf
22. B.J. Monk, D.S. Alberts, and R.A. Burger In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers Gynecol Oncol 71 2 1998 308 312 (Pubitemid 28550818)
23. A. Brock, W. Prager, R. Bohme, and S. Pohlmann The methods and results of simultaneous radiochemotherapy with carboplatin in advanced cervical carcinomas Strahlenther Onkol 170 5 1994 264 268 (Pubitemid 24167645)
24. G.R. Weiss, S. Green, and E.V. Hannigan A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: a Southwest Oncology Group study Gynecol Oncol 39 3 1990 332 336
25. W.P. McGuire III, J. Arseneau, and J.A. Blessing A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study J Clin Oncol 7 10 1989 1462 1468
26. C.A. Papadimitriou, K. Sarris, and L.A. Moulopoulos Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix J Clin Oncol 17 3 1999 761 766 (Pubitemid 29109303)
27. M.S. Piver, S.A. Ghamande, G.H. Eltabbakh, and C. O'Neill-Coppola First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix-a phase II study Gynecol Oncol 75 3 1999 334 337
28. K. Kim, E.K. Chie, and H.G. Wu Efficacy of paclitaxel and carboplatin as a regimen for postoperative concurrent chemoradiotherapy of high risk uterine cervix cancer Gynecol Oncol 101 3 2006 398 402 (Pubitemid 43729969)
29. M.Y. Lee, H.G. Wu, and K. Kim Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix Gynecol Oncol 104 1 2007 95 99 (Pubitemid 46054128)
30. H.J. Kim, S.W. Ha, and H.G. Wu Treatment outcomes and prognostic factors in uterine cervical cancer patients treated with postoperative extended field radiation therapy J Gynecol Oncol 20 4 2009 227 231